2024-511949-19-00CompletedPhase 1
An Open-Label, Multicenter, Phase 1 Study Evaluating the Safety and Pharmacokinetics of ADU-1604 in Adults with Advanced Melanoma
Source: EU CTIS (euclinicaltrials.eu) · Last updated 9 Mar 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- First submitted
- 30 Apr 2024
- Start date
- 1 Dec 2024
- Lead sponsor
- Sairopa B.V.
- Diseases
- Melanoma
- EU CT number
- 2024-511949-19-00
- EudraCT number
- 2021-002623-38
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 44
- 11 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (11)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Clinic de Barcelona | Barcelona | Spain | Completed |
| Hospital Universitario 12 de Octubre | Madrid | Spain | Completed |
| Hospital General Universitario Gregorio Marañón | Madrid | Spain | Completed |
| Centre Hospitalier Regional De Marseille | Marseille | France | Completed |
| Hopital Saint Louis | Paris | France | Completed |
| Institut Gustave Roussy | Villejuif | France | Completed |
| Istituto Europeo di Oncologia s.r.l | Milan | Italy | Completed |
| IRCCS Istituto Nazionale Tumori Fondazione Pascale | Naples | Italy | Completed |
| Istituto Oncologico Veneto | Padova | Italy | Completed |
| Azienda Ospedaliera Universitaria Senese | Siena | Italy | Completed |
| Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy | Warsaw | Poland | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.